All posts by: Michael Zand

About Michael Zand

Clearing a way through the CRISPR patent jungle – Life Sciences Intellectual Property Review

Continue reading

2018-05-09 NEWS

Life Sciences Intellectual Property Review

Clearing a way through the CRISPR patent jungle
Life Sciences Intellectual Property Review
The revocation of the Broad Institute’s patent EP2771468, reported and discussed here, marks the latest major development in a series of patent battles over the revolutionary and highly lucrative CRISPR/Cas 9 technology (and other gene-editing

Continue reading

2018-05-09 NEWS

wwlp.com

How immunotherapy has changed the way we treat melanoma
wwlp.com
“The advances in five years that they’ve made in treatments, this immunotherapy, now, they’re referring to as ‘a game changer.’ The melanoma that went into my lungs, and then we treated it with immunotherapy for two years, and now it’s, it’s in

Continue reading

2018-05-08 NEWS

UMN News

Research Brief: Crowdfunding campaigns for unproven stem cell-based interventions
UMN News
“Our research suggests patients are deeply influenced by the misrepresentations clinics commonly use when marketing unproven stem cell ‘treatments,’” said Leigh Turner, Ph.D., associate professor in the Center for Bioethics and one of the study’s authors.
Crowdfunding campaigns sow misinformation about stemcell treatments, study findsToronto Star
Crowdfunding campaign enhances stem cell benefitsWeek Facts

all 3 news articles »